Jacobson CA - Search Results

1

Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEG.

Eckhardt CA, Sun H, Malik P, Quadri S, Santana Firme M, Jones DK, van Sleuwen M, Jain A, Fan Z, Jing J, Ge W, Danish HH, Jacobson CA, Rubin DB, Kimchi EY, Cash SS, Frigault MJ, Lee JW, Dietrich J, Westover MB. Eckhardt CA, et al. Among authors: jacobson ca. Ann Clin Transl Neurol. 2023 Oct;10(10):1776-1789. doi: 10.1002/acn3.51866. Epub 2023 Aug 6. Ann Clin Transl Neurol. 2023. PMID: 37545104 Free PMC article.

2

Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy.

Rubin DB, Al Jarrah A, Li K, LaRose S, Monk AD, Ali AB, Spendley LN, Nikiforow S, Jacobson C, Vaitkevicius H. Rubin DB, et al. JAMA Neurol. 2020 Dec 1;77(12):1536-1542. doi: 10.1001/jamaneurol.2020.2703. JAMA Neurol. 2020. PMID: 32777012 Free PMC article.

3

Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell Therapy.

Johnson PC, Jacobson C, Yi A, Saucier A, Dhawale TM, Nelson A, Lavoie MW, Reynolds MJ, Topping CEW, Frigault MJ, El-Jawahri A. Johnson PC, et al. J Natl Compr Canc Netw. 2021 Mar 11;19(8):928-934. doi: 10.6004/jnccn.2020.7678. J Natl Compr Canc Netw. 2021. PMID: 33706257

4

Risk Factors With Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy-Reply.

Rubin DB, Jacobson C, Vaitkevicius H. Rubin DB, et al. JAMA Neurol. 2021 Jun 1;78(6):764-765. doi: 10.1001/jamaneurol.2021.0893. JAMA Neurol. 2021. PMID: 33900372 No abstract available.

5

EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations.

Beuchat I, Danish HH, Rubin DB, Jacobson C, Robertson M, Vaitkevicius H, Lee JW. Beuchat I, et al. Neuro Oncol. 2022 Feb 1;24(2):313-325. doi: 10.1093/neuonc/noab174. Neuro Oncol. 2022. PMID: 34265061 Free PMC article.

6

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma.

Haradhvala NJ, Leick MB, Maurer K, Gohil SH, Larson RC, Yao N, Gallagher KME, Katsis K, Frigault MJ, Southard J, Li S, Kann MC, Silva H, Jan M, Rhrissorrakrai K, Utro F, Levovitz C, Jacobs RA, Slowik K, Danysh BP, Livak KJ, Parida L, Ferry J, Jacobson C, Wu CJ, Getz G, Maus MV. Haradhvala NJ, et al. Nat Med. 2022 Sep;28(9):1848-1859. doi: 10.1038/s41591-022-01959-0. Epub 2022 Sep 12. Nat Med. 2022. PMID: 36097221 Free PMC article.

7

Use of Transcranial Doppler as a Biomarker of CAR T Cell-Related Neurotoxicity.

Holroyd KB, Rubin DB, LaRose S, Monk A, Nikiforow S, Jacobson C, Vaitkevicius H. Holroyd KB, et al. Neurol Clin Pract. 2022 Feb;12(1):22-28. doi: 10.1212/CPJ.0000000000001130. Neurol Clin Pract. 2022. PMID: 36157627 Free PMC article.

8

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.

Maurer K, Saucier A, Kim HT, Acharya U, Mo CC, Porter J, Albert C, Cutler C, Antin JH, Koreth J, Gooptu M, Romee R, Wu CJ, Soiffer RJ, Nikiforow S, Jacobson C, Ho VT. Maurer K, et al. Blood Adv. 2021 Feb 9;5(3):861-871. doi: 10.1182/bloodadvances.2020003883. Blood Adv. 2021. PMID: 33560397 Free PMC article.

9

Immune and Cell Therapy in Non-Hodgkin Lymphoma.

Merryman RW, Houot R, Armand P, Jacobson C. Merryman RW, et al. Cancer J. 2020 May/Jun;26(3):269-277. doi: 10.1097/PPO.0000000000000445. Cancer J. 2020. PMID: 32496460 Review.

10

Chimeric Antigen Receptor T Cells for B-Cell Lymphoma.

Newcomb R, Jacobson C. Newcomb R, et al. Cancer J. 2021 Mar-Apr 01;27(2):107-111. doi: 10.1097/PPO.0000000000000509. Cancer J. 2021. PMID: 33750069 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page